Altum Sequencing
Madrid, ES · 1 known investors
Find your way into Altum Sequencing
Sign up to see every warm intro you have to Altum Sequencing
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Altum Sequencing team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Altum Sequencing develops ultra-sensitive, tumor-informed liquid biopsy (ctDNA) tests paired with an AI-driven platform to detect cancer relapse and measure treatment response at the molecular level. It serves clinicians and researchers in oncology and hematology, covering both hematologic malignancies and solid tumors.
Founders & leadership
JM

Joaquín MartínezChairman and Co-FounderA hematologist and professor of medicine at Universidad Complutense de Madrid and head of the Medical Oncology Department at Hospital Universitario 12 de Octubre, Martínez co-founded Altum Sequencing to develop molecular diagnostics and disease monitoring approaches in oncology.
JM
Joaquin MartinezCo-founder
RA
Rosa AyalaCo-founder
LP
Luis Paz-AresCo-founder
JF
Jaume FerréCTO
Investors · 1
In the news
Frequently asked questions
- What does Altum Sequencing do?
- Altum Sequencing develops ultra-sensitive, tumor-informed liquid biopsy (ctDNA) tests paired with an AI-driven platform to detect cancer relapse and measure treatment response at the molecular level. It serves clinicians and researchers in oncology and hematology, covering both hematologic malignancies and solid tumors.
- Who founded Altum Sequencing?
- Altum Sequencing was founded by Joaquín Martínez.
- Who are Altum Sequencing's investors?
- Altum Sequencing's investors include Ship2B.
- Where is Altum Sequencing headquartered?
- Altum Sequencing is headquartered in Madrid, ES.

